全文获取类型
收费全文 | 522篇 |
免费 | 10篇 |
国内免费 | 8篇 |
专业分类
儿科学 | 18篇 |
妇产科学 | 5篇 |
基础医学 | 44篇 |
口腔科学 | 5篇 |
临床医学 | 69篇 |
内科学 | 139篇 |
皮肤病学 | 8篇 |
神经病学 | 11篇 |
特种医学 | 94篇 |
外国民族医学 | 1篇 |
外科学 | 34篇 |
综合类 | 6篇 |
预防医学 | 24篇 |
眼科学 | 1篇 |
药学 | 34篇 |
肿瘤学 | 47篇 |
出版年
2021年 | 5篇 |
2019年 | 4篇 |
2015年 | 6篇 |
2014年 | 8篇 |
2013年 | 6篇 |
2012年 | 9篇 |
2011年 | 15篇 |
2010年 | 24篇 |
2009年 | 15篇 |
2008年 | 19篇 |
2007年 | 21篇 |
2006年 | 23篇 |
2005年 | 9篇 |
2004年 | 6篇 |
2003年 | 9篇 |
2002年 | 8篇 |
2001年 | 8篇 |
2000年 | 7篇 |
1998年 | 19篇 |
1997年 | 19篇 |
1996年 | 14篇 |
1995年 | 13篇 |
1994年 | 15篇 |
1993年 | 15篇 |
1992年 | 8篇 |
1991年 | 11篇 |
1990年 | 10篇 |
1989年 | 16篇 |
1988年 | 15篇 |
1987年 | 16篇 |
1986年 | 18篇 |
1985年 | 11篇 |
1984年 | 6篇 |
1982年 | 10篇 |
1981年 | 6篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1978年 | 9篇 |
1977年 | 12篇 |
1976年 | 10篇 |
1975年 | 14篇 |
1974年 | 3篇 |
1973年 | 5篇 |
1972年 | 6篇 |
1971年 | 3篇 |
1970年 | 4篇 |
1969年 | 2篇 |
1968年 | 7篇 |
1967年 | 4篇 |
1965年 | 4篇 |
排序方式: 共有540条查询结果,搜索用时 171 毫秒
91.
92.
93.
94.
Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians 总被引:4,自引:0,他引:4
Pavkov ME Knowler WC Bennett PH Looker HC Krakoff J Nelson RG 《Kidney international》2006,70(10):1840-1846
The introduction of more efficacious treatments for diabetic kidney disease may slow its progression, but evidence for their effectiveness in populations is sparse. We examined trends in the incidence of clinical proteinuria, defined as a urinary protein-to-creatinine ratio >0.5 g/g, and diabetic end-stage renal disease (ESRD), defined as death from diabetic nephropathy or onset of dialysis, in Pima Indians with type 2 diabetes between 1967 and 2002. The study included 2189 diabetic subjects >/=25 years old. During follow-up, 366 incident cases of proteinuria occurred in the subset of 1715 subjects without proteinuria at baseline. The age-sex-adjusted incidence rate of proteinuria increased from 24.3 cases/1000 person-years (pyrs) (95% confidence interval (CI) 18.7-30.0) in 1967-1978 to 35.4 cases/1000 pyrs (95% CI 28.1-42.8) in 1979-1990 and 38.9 cases/1000 pyrs (95% CI 31.2-46.5) in 1991-2002 (P(trend)<0.0002). In each period, the age-sex-adjusted incidence of proteinuria increased with diabetes duration, but diabetes duration-specific incidence was stable throughout the study period (P=0.8). The age-sex-adjusted incidence of ESRD increased between 1967 and 1990 and declined thereafter. The incidence of proteinuria increased over 36 years in Pima Indians as the proportion of people with diabetes of long duration increased. On the other hand, the incidence of ESRD declined after 1990, coinciding with improved control of blood pressure, hyperglycemia, and perhaps other risk factors. 相似文献
95.
96.
97.
98.
Administration of gallium nitrate to rats resulted in the formation of renal precipitates which occluded tubular lumina. When analyzed with a combination of scanning electron microscopy and x-ray energy spectrometry, these precipitates were found to contain gallium complexed with calcium and phosphate. Injection of gallium nitrate also resulted in hypercalciuria, although serum calcium levels remained unaltered. Administration of an osmotic diuretic, isosorbide, prior to gallium treatment resulted in the formation of fewer renal precipitates and histopathologic changes than in the nondiuresed animals. Diuresis did not alter gallium serum pharmacokinetics, the 24 hour cumulative renal excretion of gallium or the extent of the drug-induced hypercalciuria. However, isosorbide pretreatment significantly reduced the urinary concentrations of both gallium and calcium. The data presented indicate that diuresis reduces the severity of gallium-induced renal lithiasis and subsequent renal accumulation of gallium by diluting the urinary concentration of gallium and calcium thereby lowering the incidence of interaction of these two elements within the kidney tubule. 相似文献
99.
100.
Krakoff LR 《Hypertension》2006,47(1):29-34
Accurate diagnosis of hypertension and prognosis for future cardiovascular events can be enhanced through the use of 24-hour ambulatory blood pressure monitoring. It has been suggested that the use of ambulatory monitoring as a secondary screening for hypertension might be cost-effective. Many needed studies that are related to the calculation of cost-effectiveness for ambulatory monitoring have become available in recent years. More accurate estimates for cost of care, costs for testing, prevalence of white-coat hypertension, and incidence of the transition from normal pressures to hypertension have been reported. This study presents calculations of the cost savings likely to take place when ambulatory blood pressure monitoring is implemented for newly detected hypertensive subjects. These calculations are based on current estimates for cost of testing, cost of treatment, prevalence of white-coat hypertension at baseline, and varying the incidence of new hypertension after the initial screening. The results indicate a potential savings of 3% to 14% for cost of care for hypertension and 10% to 23% reduction in treatment days when ambulatory blood pressure monitoring is incorporated into the diagnostic process. At current reimbursement rates, the cost of ambulatory blood pressure monitoring for secondary screening on an annual basis would be <10% of treatment costs. Calculated savings for use of ambulatory blood pressure monitoring can take place when annual treatment costs are as little as 300 dollars. These estimates should be considered for the management of recently detected hypertension, especially when the risk of future cardiovascular is disease is low. 相似文献